M13-576
ClinicalTrials.gov NCT02441283
Research payments
$180,818
Through program year 2020, $180,818 in research payments was reported against M13-576, across 150 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT02441283
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $59,770 | 73 |
| 2019 | Research | $121,048 | 77 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Franco Felizarta Bakersfield, CA Named on 68 payments
- Reem Ghalib Arlington, TX Named on 20 payments
- Humberto Aguilar Shreveport, LA Named on 11 payments
- Stuart Gordon Detroit, MI Named on 7 payments
- Steven Mannis Escondido, CA Named on 7 payments
- Moti Ramgopal Fort Pierce, FL Named on 6 payments
- Fred Poordad San Antonio, TX Named on 6 payments
- Robert Reindollar Charlotte, NC Named on 4 payments
- Edward Galen Portland, OR Named on 3 payments
- Federico Rodriguez Perez San Juan, PR Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.